Glenn Coleman Integra Lifesciences Holdings Corp (IART) insider trading activity

Glenn Coleman is Executive Vice President & COO of INTEGRA LIFESCIENCES HOLDINGS CORP. Currently has a direct ownership of 34,622 shares of IART, which is worth approximately $766,184. The most recent transaction as insider was on Jul 01, 2022, when has been sold 6,666 shares (Common Stock) at a price of $55.0 per share, resulting in proceeds of $366,630. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 34.6K

0% 3M change

0% 12M change

Total Value Held $766,184

Glenn Coleman Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jul 01 2022	SELL Payment of exercise price or tax liability	$366,630 $55.0 p/Share	6,666 Reduced 16.15%	34,622 Common Stock
Apr 04 2022	SELL Open market or private sale	$413,939 $66.04 p/Share	6,268 Reduced 13.18%	41,288 Common Stock
Mar 13 2022	SELL Payment of exercise price or tax liability	$679,683 $65.11 p/Share	10,439 Reduced 18.0%	47,556 Common Stock
Mar 12 2022	SELL Payment of exercise price or tax liability	$428,619 $65.11 p/Share	6,583 Reduced 10.19%	57,995 Common Stock
Mar 11 2022	BUY Grant, award, or other acquisition	-	7,119 Added 9.93%	64,578 Common Stock
Feb 11 2022	BUY Grant, award, or other acquisition	-	29,305 Added 33.78%	57,459 Common Stock
Nov 02 2021	SELL Open market or private sale	$316,350 $74.0 p/Share	4,275 Reduced 13.34%	27,781 Common Stock
Apr 16 2021	SELL Open market or private sale	$1,834,547 $71.5 p/Share	25,658 Reduced 44.46%	32,056 Common Stock
Apr 16 2021	BUY Exercise of conversion of derivative security	$498,022 $19.41 p/Share	25,658 Added 30.78%	57,714 Common Stock
Apr 14 2021	SELL Open market or private sale	$282,141 $70.5 p/Share	4,002 Reduced 11.1%	32,056 Common Stock
Apr 09 2021	SELL Open market or private sale	$875,000 $70.0 p/Share	12,500 Reduced 25.74%	36,058 Common Stock
Apr 09 2021	BUY Exercise of conversion of derivative security	$242,625 $19.41 p/Share	12,500 Added 20.47%	48,558 Common Stock
Mar 29 2021	SELL Open market or private sale	$1,061,750 $68.5 p/Share	15,500 Reduced 30.06%	36,058 Common Stock
Mar 29 2021	BUY Exercise of conversion of derivative security	$242,625 $19.41 p/Share	12,500 Added 20.47%	48,558 Common Stock
Mar 13 2021	SELL Payment of exercise price or tax liability	$138,107 $68.1 p/Share	2,028 Reduced 4.94%	39,058 Common Stock
Mar 12 2021	BUY Grant, award, or other acquisition	-	6,807 Added 14.21%	41,086 Common Stock
Nov 13 2020	SELL Open market or private sale	$145,678 $56.03 p/Share	2,600 Reduced 7.12%	33,894 Common Stock
Nov 09 2020	SELL Open market or private sale	$518,316 $55.14 p/Share	9,400 Reduced 20.48%	36,494 Common Stock

Also insider at

XRAY

DENTSPLY SIRONA Inc. Healthcare

Executive VP & CFO

PINC

Premier, Inc. Healthcare

CAO & CFO

Glenn Coleman

Executive Vice President & COO

Princeton, NJ

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells IART shares.

Notify only if

Value

Insider Trading

Get notified when an Integra Lifesciences Holdings Corp insider buys or sells IART shares.

Notify only if

Operation

Value

Type

News

Receive news related to INTEGRA LIFESCIENCES HOLDINGS CORP

Track Activities on IART

Account